Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy
(Q43974807)
scientific article published in May 2002
scientific article published in May 2002
Language:
Current Data About
Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||
| (P50) |
(Q96203215)
|
||||||||||||||||||||||||
| (P304) |
1022-1030
|
||||||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||||||
| (P433) |
5
|
||||||||||||||||||||||||
| (P478) |
35
|
||||||||||||||||||||||||
| (P577) |
Wednesday, May 1, 2002
|
||||||||||||||||||||||||
| (P1433) |
(Q15724398)
|
||||||||||||||||||||||||
| (P1476) |
"Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy" (language: en)
|
||||||||||||||||||||||||
| (P2093) |
Yutaka Yata
Philip Gotwals
Don C Rockey
|